138 related articles for article (PubMed ID: 36861433)
1. Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
Berger M; Solelhac G; Marchi NA; Dussez R; Bradley B; Lecciso G; Heiniger G; Bayon V; Van Den Broecke S; Haba-Rubio J; Siclari F; Heinzer R
Sleep; 2023 Jul; 46(7):. PubMed ID: 36861433
[TBL] [Abstract][Full Text] [Related]
2. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
[TBL] [Abstract][Full Text] [Related]
3. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
[TBL] [Abstract][Full Text] [Related]
4. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
5. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
6. Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation.
Perger E; Castiglioni P; Faini A; Soranna D; Zambon A; Rosa D; Vicini S; Meriggi P; Pini L; Baratto C; Caravita S; Azarbarzin A; Parati G; Lombardi C
Sci Rep; 2023 Feb; 13(1):3178. PubMed ID: 36823241
[TBL] [Abstract][Full Text] [Related]
7. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
[TBL] [Abstract][Full Text] [Related]
8. Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals.
Lim R; Carberry JC; Wellman A; Grunstein R; Eckert DJ
Sleep; 2019 Apr; 42(4):. PubMed ID: 30590857
[TBL] [Abstract][Full Text] [Related]
9. The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.
Combs D; Edgin J; Hsu CH; Bottrill K; Van Vorce H; Gerken B; Matloff D; La Rue S; Parthasarathy S
J Clin Sleep Med; 2023 Dec; 19(12):2065-2073. PubMed ID: 37555595
[TBL] [Abstract][Full Text] [Related]
10. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
11. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Corser B; Eves E; Warren-McCormick J; Rucosky G
J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled, crossover study of respiratory safety of lemborexant in moderate to severe obstructive sleep apnea.
Cheng JY; Lorch D; Lowe AD; Uchimura N; Hall N; Shah D; Moline M
J Clin Sleep Med; 2024 Jan; 20(1):57-65. PubMed ID: 37677076
[TBL] [Abstract][Full Text] [Related]
13. Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea: A Randomized, Double-Blind Crossover Study.
Schmickl CN; Li Y; Orr JE; Jen R; Sands SA; Edwards BA; DeYoung P; Owens RL; Malhotra A
Chest; 2020 Aug; 158(2):765-775. PubMed ID: 32278781
[TBL] [Abstract][Full Text] [Related]
14. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA.
Rosenberg R; Abaluck B; Thein S
J Clin Sleep Med; 2022 Dec; 18(12):2837-2844. PubMed ID: 35975547
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA
Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600
[TBL] [Abstract][Full Text] [Related]
16. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
17. The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
Schweitzer PK; Taranto-Montemurro L; Ojile JM; Thein SG; Drake CL; Rosenberg R; Corser B; Abaluck B; Sangal RB; Maynard J
Am J Respir Crit Care Med; 2023 Dec; 208(12):1316-1327. PubMed ID: 37812772
[No Abstract] [Full Text] [Related]
18. Anti-inflammatory medications for obstructive sleep apnoea in children.
Kuhle S; Hoffmann DU; Mitra S; Urschitz MS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007074. PubMed ID: 31978261
[TBL] [Abstract][Full Text] [Related]
19. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial.
Nussbaumer-Ochsner Y; Latshang TD; Ulrich S; Kohler M; Thurnheer R; Bloch KE
Chest; 2012 Jan; 141(1):131-138. PubMed ID: 21659435
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of mirtazapine in obstructive sleep apnea syndrome.
Carley DW; Olopade C; Ruigt GS; Radulovacki M
Sleep; 2007 Jan; 30(1):35-41. PubMed ID: 17310863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
